| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2023 | Mar 9, 2023 | T2 Biosystems, Inc. | CFO | Sell | 25.0 | -2,693 | -17.42% | ✓ | $1.7K |
| Apr 8, 2022 | Apr 11, 2022 | T2 Biosystems, Inc. | CFO | Buy | 85.0 | +10,000 | 7.02% | ✗ | $4.8K |
| Feb 24, 2022 | Mar 29, 2022 | T2 Biosystems, Inc. | CFO | Sell | 46.3 | -55,008 | -27.87% | ✗ | $24.7K |
| Feb 21, 2022 | Mar 29, 2022 | T2 Biosystems, Inc. | CFO | Sell | 47.5 | -3,775 | -6.81% | ✗ | $1.8K |
| Feb 24, 2022 | Feb 28, 2022 | T2 Biosystems, Inc. | CFO | Sell | 46.3 | -55,008 | -28.77% | ✗ | $24.7K |
| Feb 21, 2022 | Feb 23, 2022 | T2 Biosystems, Inc. | CFO | Sell | 47.5 | -3,775 | -7.66% | ✗ | $1.8K |
| Feb 21, 2021 | Feb 23, 2021 | T2 Biosystems, Inc. | CFO | Sell | 28.8 | -5,250 | -12.89% | ✓ | $10.7K |
| Feb 21, 2020 | Mar 3, 2020 | T2 Biosystems, Inc. | CFO | Sell | 27.5 | -4,166 | -15.79% | ✗ | $3.4K |
| Jul 20, 2018 | Jul 24, 2018 | T2 Biosystems, Inc. | CFO | Sell | 26.3 | -5,619 | -32.49% | ✗ | $37.8K |